Testing a drug to prevent blood clots after pancreas transplant
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests whether a drug called anakinra can prevent blood clots (immunothrombosis) after a pancreas transplant. If you are scheduled for a pancreas transplant (alone or with a kidney) at Nantes University Hospital, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a pancreas transplant (alone or with a kidney) at Nantes University Hospital.
- This can be your first, second, or third pancreas transplant.
- You are covered by French social security.
- You are able to give written consent and speak French.
- Women must use effective contraception and have a negative pregnancy test before the first dose, be postmenopausal, or have had certain surgeries. Men with partners must use condoms during the trial and for 90 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who receive a pancreas transplant, with or without a same-time kidney transplant, and follows them to understand their results. It may help improve how transplant teams choose patients and manage care after surgery.
This trial tests a treatment approach for people who develop tremors after a combined pancreas and kidney transplant. It aims to improve tremor symptoms while keeping transplant organs functioning steadily.
This Phase 2 study tests whether adding anakinra (an immune signal blocker) to standard chemotherapy can improve outcomes for some people with pancreatic ductal adenocarcinoma. It’s mainly for adults with stage I–III disease who have enough organ function and are able to come in for treatment and follow-up.
This trial tests whether blocking a protein called IL-1 with a single dose of anakinra can reduce swelling in the donor lung during the transplant process. If you are having a lung transplant and your donor lung is treated with a machine that keeps it alive outside the body (EVLP), you may be able to join.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This study tests if octreotide microspheres (a slow-release drug) can prevent pancreatic fistula—a common complication after surgery to remove the tail of the pancreas. The goal is to help patients heal with fewer complications.
Hear when a new Pancreatic Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.